MAPC Transplantation Confers a more Durable Benefit than AC133+ Cell Transplantation in Severe Hind Limb Ischemia

Title
MAPC Transplantation Confers a more Durable Benefit than AC133+ Cell Transplantation in Severe Hind Limb Ischemia
Authors
Keywords
-
Journal
CELL TRANSPLANTATION
Volume 20, Issue 2, Pages 259-270
Publisher
SAGE Publications
Online
2011-04-18
DOI
10.3727/096368910x516592

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started